These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


830 related items for PubMed ID: 15513337

  • 1. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE, Tofteng F, Strauss GI, Larsen FS.
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [Abstract] [Full Text] [Related]

  • 2. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy.
    Koivusalo AM, Teikari T, Höckerstedt K, Isoniemi H.
    Metab Brain Dis; 2008 Dec; 23(4):387-98. PubMed ID: 18773287
    [Abstract] [Full Text] [Related]

  • 3. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure.
    Schmidt LE, Svendsen LB, Sørensen VR, Hansen BA, Larsen FS.
    Liver Transpl; 2001 Aug; 7(8):709-12. PubMed ID: 11510016
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure.
    Tsai MH, Chen YC, Wu CS, Ho YP, Fang JT, Lien JM, Yang C, Chu YY, Liu NJ, Lin CH, Chiu CT, Chen PC.
    Int J Clin Pract; 2005 Nov; 59(11):1289-94. PubMed ID: 16236082
    [Abstract] [Full Text] [Related]

  • 6. Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorption.
    Rifai K, Das A, Rosenau J, Ernst T, Kretschmer U, Haller H, Fliser D, Manns MP.
    Artif Organs; 2010 Feb; 34(2):166-70. PubMed ID: 19817727
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome.
    Aggarwal S, Obrist W, Yonas H, Kramer D, Kang Y, Scott V, Planinsic R.
    Liver Transpl; 2005 Nov; 11(11):1353-60. PubMed ID: 16237715
    [Abstract] [Full Text] [Related]

  • 10. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
    Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella SM, Novelli S, Spoletini G, Ferretti G, Mennini G, Berloco PB.
    Transplant Proc; 2008 Nov; 40(6):1921-4. PubMed ID: 18675090
    [Abstract] [Full Text] [Related]

  • 11. [The treatment of molecular adsorbents recirculating system artificial liver in severe liver failure patients with multiple organ dysfunction syndrome].
    Guo LM, Liu JY, Xu DZ, Li BS, Han H, Wang LH, Zhang WY, Lu LH, Guo X, Sun FX, Zhang HY, Liu XD, Zhang JP, Yao J, He ZP, Wang MM.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):455-7. PubMed ID: 12939172
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
    Tan HK, Yang WS, Chow P, Lui HF, Choong HL, Wong KS.
    Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
    Camus C, Lavoué S, Gacouin A, Compagnon P, Boudjéma K, Jacquelinet C, Thomas R, Le Tulzo Y.
    Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
    Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Nöldge-Schomburg G.
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.